S7 Data - by Renjie Wang (1986553)

“…Pn decreased significantly across treatments, with D1CK>D2>D3. …”

Study scheme. by Ayako Shoji (78037)

“…The incidence rate of suspected mild cognitive impairment was significantly lower in the post-CHAP group even after adjusted known factors associated with cognitive disorders. …”

Characteristics of the participants. by Ayako Shoji (78037)

“…The incidence rate of suspected mild cognitive impairment was significantly lower in the post-CHAP group even after adjusted known factors associated with cognitive disorders. …”

Incidence rates of sMCI and sSCI. by Ayako Shoji (78037)

“…The incidence rate of suspected mild cognitive impairment was significantly lower in the post-CHAP group even after adjusted known factors associated with cognitive disorders. …”

Illustrative images of the quantitative processing of polar maps from a myocardial perfusion study in one of the investigated patients. by Káryta Suely Macêdo Martins (22404155)

Health Risks of Low-Dose Dietary Exposure to Triphenyl Phosphate and Diphenyl Phosphate in Mice: Insights from the Gut–Liver Axis by Jing Cao (287196)

“…Decreased liver carbohydrate levels and insulin resistance were observed in the DPHP-fed mice. …”

Additional questions on vaccination. by Sara Saleh (6733619)

“…However, only 43.3% exhibited good vaccination practices. Significant disparities were observed in rural regions such as Beqaa, where mothers had the lowest education levels, the highest rates of poor knowledge (11.9%), and the lowest vaccination practice scores (32.7%). …”

The raw data file. by Sara Saleh (6733619)

“…However, only 43.3% exhibited good vaccination practices. Significant disparities were observed in rural regions such as Beqaa, where mothers had the lowest education levels, the highest rates of poor knowledge (11.9%), and the lowest vaccination practice scores (32.7%). …”

The acutely infected population at an endemic equilibrium, for different <i>α</i> values. by Meriem Boukaabar (19704258)

Ranking position of feature importance for each cluster in the post-vaccination period. by Jéssica Villar (21453137)

Ranking position of feature importance for each cluster in the pre-vaccination period. by Jéssica Villar (21453137)

Identifying optimal cluster numbers in hierarchical cluster analysis. by Dolores Bernenko (16528426)

CONSORT flow diagram. by Mehran Asadi-Aliabadi (8383110)

“…The interventions had statistically significant effects only on decreasing the prevalence of overweight and obesity. …”

KEGG enrichment pathway chart (bubble chart) (A) mild PTOA group VS severe PTOA group (B) mild PTOA group VS normal group (C) Severe PTOA group VS normal group. by Peng-fei Han (694841)

a, Anti-correlation of gene expression between <i>dmdR1</i> and its predicted regulon. Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875.... by Hannah E. Augustijn (10773096)

“…Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875. …”

Summary of study eligibility criteria. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”

Summary of study participation and feasibility. by Biban Gill (1473337)

“…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”

Antibody description. by Qi He (384033)

“…Furthermore, HRW decreased Cytc, Bax, Caspase-3, and Caspase-8 levels, and increasing the expression of Bcl-2. …”

Raw data of this article. by Qi He (384033)

“…Furthermore, HRW decreased Cytc, Bax, Caspase-3, and Caspase-8 levels, and increasing the expression of Bcl-2. …”

Joinpoint regression analysis of the trends in age-standardised rates of CRC burden in five East Asian countries, the United States, and globally, 1990–2021. by Yuanyi Cao (22394797)